Indications for renal biopsy in patients with diabetes. Joint position statement of the Italian Society of Nephrology and the Italian Diabetes Society

被引:8
|
作者
Di Paolo, Salvatore [1 ]
Fiorentino, Marco [1 ]
De Nicola, Luca [2 ]
Reboldi, Gianpaolo [3 ]
Gesualdo, Loreto [4 ,5 ]
Barutta, Federica [6 ]
Natali, Andrea [7 ,8 ]
Penno, Giuseppe [7 ,9 ]
Fioretto, Paola [10 ,11 ]
Pugliese, Giuseppe [12 ,13 ]
机构
[1] Mons Dimiccoli Hosp, Nephrol Unit, Viale Ippocrate 15, I-70051 Barletta, Italy
[2] Univ Campania Luigi Vanvitelli, Dept Adv Med & Surg Sci, Nephrol & Dialysis Unit, Naples, Italy
[3] Univ Perugia, Dept Med, Perugia, Italy
[4] Aldo Moro Univ, Dept Emergency & Organ Transplantat, Bari, Italy
[5] Policlin Univ Hosp, Nephrol Dialysis & Transplantat Unit, Bari, Italy
[6] Univ Turin, Dept Med Sci, Turin, Italy
[7] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy
[8] Univ Hosp, Unit Internal Med, Pisa, Italy
[9] Univ Hosp, Diabet Unit, Pisa, Italy
[10] Univ Padua, Dept Med, Padua, Italy
[11] Hosp Padua, Unit Med Clin 3, Padua, Italy
[12] Univ Roma La Sapienza, Dept Clin & Mol Med, Rome, Italy
[13] St Andrea Univ Hosp, Endocrine & Metab Unit, Rome, Italy
关键词
Renal biopsy; Diabetic kidney disease (DKD); Diabetic nephropathy (DN); Non-diabetic renal disease (NDRD); DKD phenotypes; GLOMERULAR-FILTRATION-RATE; KIDNEY-DISEASE; CLINICAL PREDICTORS; NEPHROPATHY; PROGRESSION; PATTERNS; OUTCOMES; DECLINE; ALBUMINURIA; MELLITUS;
D O I
10.1016/j.numecd.2020.09.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: This joint document of the Italian Society of Nephrology and the Italian Diabetes Society reviews the main indications to perform a renal biopsy in diabetic patients, according to the recommendations of a panel of experts based on all available scientific evidence. Data synthesis: Renal biopsy has a pivotal role in assessing the nature and severity of renal injury in patients with diabetic kidney disease (DKD). The procedure is mandatory in the presence of one of more of the following features: rapid onset or progression of albuminuria or sudden onset of nephrotic syndrome, rapid GFR decline with or without albuminuria, hematuria, active urine sediment, clinical and/or laboratory suspicion of other systemic diseases, and, in patients with type 1 diabetes, short diabetes duration and absence of retinopathy. Indeed, similar to 40% of diabetic individuals with kidney injury undergoing renal biopsy are affected by a non-diabetic renal disease (NDRD). Furthermore, the histological evaluation of patients with suspected classical diabetic nephropathy allows to define the extent of glomerular, tubulo-interstitial and vascular lesions, thus providing important prognostic (and potentially therapeutic) data. In the future, the indications for renal biopsy might be extended to the definition of the histological lesions underlying the "nonalbuminuric" DKD phenotypes, as well as to the evaluation of the response to treatment with the new anti-hyperglycemic drugs that provide cardiorenal protection. Conclusions: In view of the heterogeneous clinical presentation and course of DKD and of the related heterogeneous histopathological patterns, a more extensive use of renal biopsy may be crucial to provide valuable information with important pathogenic, diagnostic, prognostic, and therapeutic implications. (C) 2020 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:2123 / 2132
页数:10
相关论文
共 50 条
  • [41] Regional citrate anticoagulation for renal replacement therapies in patients with acute kidney injury: a position statement of the Work Group "Renal Replacement Therapies in Critically Ill Patients" of the Italian Society of Nephrology
    Fiaccadori, Enrico
    Pistolesi, Valentina
    Mariano, Filippo
    Mancini, Elena
    Canepari, Giorgio
    Inguaggiato, Paola
    Pozzato, Marco
    Morabito, Santo
    JOURNAL OF NEPHROLOGY, 2015, 28 (02) : 151 - 164
  • [42] DIABETES CONTROL AND COMPLICATIONS TRIAL - POSITION STATEMENT OF THE AUSTRALIAN-DIABETES-SOCIETY
    YUE, DK
    COLAGIURI, S
    MCELDUFF, A
    SILINK, M
    MEDICAL JOURNAL OF AUSTRALIA, 1993, 159 (11-12) : 803 - 804
  • [43] Position Statement of the Chinese Diabetes Society regarding stem cell therapy for diabetes
    Zhu, Dalong
    Chen, Li
    Hong, Tianpei
    JOURNAL OF DIABETES, 2012, 4 (01) : 18 - 21
  • [44] Algorithm for the treatment of type 2 diabetes: a position statement of Brazilian Diabetes Society
    Lerario, Antonio C.
    Chacra, Antonio R.
    Pimazoni-Netto, Augusto
    Malerbi, Domingos
    Gross, Jorge L.
    Oliveira, Jose E. P.
    Gomes, Marilia B.
    Santos, Raul D.
    Fonseca, Reine M. C.
    Betti, Roberto
    Raduan, Roberto
    DIABETOLOGY & METABOLIC SYNDROME, 2010, 2
  • [45] Algorithm for the treatment of type 2 diabetes: a position statement of Brazilian Diabetes Society
    Antonio C Lerario
    Antonio R Chacra
    Augusto Pimazoni-Netto
    Domingos Malerbi
    Jorge L Gross
    José EP Oliveira
    Marilia B Gomes
    Raul D Santos
    Reine MC Fonseca
    Roberto Betti
    Roberto Raduan
    Diabetology & Metabolic Syndrome, 2
  • [46] Management of dyslipidaemia in patients with chronic kidney disease: a position paper endorsed by the Italian Society of Nephrology
    Pontremoli, Roberto
    Bellizzi, Vincenzo
    Bianchi, Stefano
    Bigazzi, Roberto
    Cernaro, Valeria
    Del Vecchio, Lucia
    De Nicola, Luca
    Leoncini, Giovanna
    Mallamaci, Francesca
    Zoccali, Carmine
    Buemi, Michele
    JOURNAL OF NEPHROLOGY, 2020, 33 (03) : 417 - 430
  • [47] Management of dyslipidaemia in patients with chronic kidney disease: a position paper endorsed by the Italian Society of Nephrology
    Roberto Pontremoli
    Vincenzo Bellizzi
    Stefano Bianchi
    Roberto Bigazzi
    Valeria Cernaro
    Lucia Del Vecchio
    Luca De Nicola
    Giovanna Leoncini
    Francesca Mallamaci
    Carmine Zoccali
    Michele Buemi
    Journal of Nephrology, 2020, 33 : 417 - 430
  • [48] Vitamin D in patients with chronic kidney disease: a position statement of the Working Group “Trace Elements and Mineral Metabolism” of the Italian Society of Nephrology
    Luigi Francesco Morrone
    Pergiorgio Bolasco
    Corrado Camerini
    Giuseppe Cianciolo
    Adamasco Cupisti
    Andrea Galassi
    Sandro Mazzaferro
    Domenico Russo
    Luigi Russo
    Mario Cozzolino
    Journal of Nephrology, 2016, 29 : 305 - 328
  • [49] Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM)
    E. Sbardella
    A. M. Isidori
    G. Arnaldi
    M. Arosio
    C. Barone
    A. Benso
    R. Berardi
    G. Capasso
    M. Caprio
    F. Ceccato
    G. Corona
    S. Della Casa
    L. De Nicola
    M. Faustini-Fustini
    E. Fiaccadori
    L. Gesualdo
    S. Gori
    A. Lania
    G. Mantovani
    P. Menè
    G. Parenti
    C. Pinto
    R. Pivonello
    P. Razzore
    G. Regolisti
    C. Scaroni
    F. Trepiccione
    A. Lenzi
    A. Peri
    Journal of Endocrinological Investigation, 2018, 41 : 3 - 19
  • [50] Vitamin D in patients with chronic kidney disease: a position statement of the Working Group "Trace Elements and Mineral Metabolism" of the Italian Society of Nephrology
    Morrone, Luigi Francesco
    Bolasco, Pergiorgio
    Camerini, Corrado
    Cianciolo, Giuseppe
    Cupisti, Adamasco
    Galassi, Andrea
    Mazzaferro, Sandro
    Russo, Domenico
    Russo, Luigi
    Cozzolino, Mario
    JOURNAL OF NEPHROLOGY, 2016, 29 (03) : 305 - 328